Latest News about CRSP
Recent news which mentions CRSP
Peloton Isn’t the ONLY Takeover Target. What Companies Could Be Bought Out in 2022?
February 23, 2022
From InvestorPlace
Why Jim Cramer Believes Sirius XM Is Inexpensive
February 23, 2022
From Benzinga
CRISPR Therapeutics's Return On Capital Employed Insights
February 16, 2022
Tickers
CRSP
From Benzinga
3 Biotech Stocks to Buy in February
February 16, 2022
From Motley Fool
2 Exciting Trends That Could Shape Healthcare's Future
February 10, 2022
From Motley Fool
Tickers
CRSP
From Motley Fool
Have $3,000? Buying These 3 Stocks Now Just Might Be the Smartest Move You'll Ever Make
February 07, 2022
From Motley Fool
Is this Beaten-Down Biotech Making a Comeback?
February 04, 2022
From Motley Fool
My Top Growth Stock to Buy in February
February 02, 2022
From Motley Fool
Here's What to Know About Vertex Pharmaceuticals' Earnings Report
February 01, 2022
From Motley Fool
5 Top Stocks for February
February 01, 2022
From Motley Fool
3 Biotech Stocks That Could Deliver 5X Gains by 2030
January 30, 2022
From Motley Fool
A Deep Dive Into the Video Game Industry
January 29, 2022
From Motley Fool
Better Biotech Stock: CRISPR Therapeutics or Twist Bioscience?
January 28, 2022
From Motley Fool
Market Dip? Here's Why This Bargain Biotech Is a Smart Buy Now
January 28, 2022
From Motley Fool
3 Green Flags for CRISPR Therapeutics' Future
January 26, 2022
From Motley Fool
Here's How Much You Would Have Made Owning CRISPR Therapeutics Stock In The Last 5 Years
January 25, 2022
Tickers
CRSP
From Benzinga
2 No-Brainer Healthcare Stocks to Buy Right Now
January 25, 2022
From Motley Fool
Is CRISPR Therapeutics a Buy?
January 24, 2022
From Motley Fool
3 Unstoppable Biotech Stocks to Buy Right Now
January 24, 2022
From Motley Fool
From Motley Fool
Buy These Stocks If You Want 126% to 206% Returns, Says Wall Street
January 18, 2022
From Motley Fool
Is Beam Therapeutics a Good Stock to Buy Now?
January 16, 2022
From Motley Fool
3 Cathie Wood Stocks That Could Deliver Bigger Gains Than the Market
January 16, 2022
From Motley Fool
3 Biotech Stocks Wall Street Thinks Could Soar 50% or More in 2022
January 14, 2022
From Motley Fool
4 Biotech Acquisitions We'd Like to See in 2022
January 14, 2022
From Motley Fool
3 Deep Value Moonshots to Ride Out Powell’s Taper Tantrum
January 10, 2022
From InvestorPlace
3 No-Brainer Big Pharma Stocks to Buy in 2022
January 09, 2022
From Motley Fool
Tickers
CRSP
From Motley Fool